Gene · 715
Papers2,917
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 2,917
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Whole-exome sequencing facilitates the differential diagnosis of Ehlers-Danlos syndrome (EDS). | Mol Genet Genomic Med | 2022 | 35119775 | PubTator, text mining | PubMed |
| Regulatory Role of Mesenchymal Stem Cells on Secondary Inflammation in Spinal Cord Injury. | J Inflamm Res | 2022 | 35115806 | PubTator, text mining | PubMed |
| RNA-seq based transcriptome analysis of ethanol extract of saffron protective effect against corticosterone-induced PC12 cell injury. | BMC Complement Med Ther | 2022 | 35101009 | PubTator, text mining | PubMed |
| Complement evasion factor (CEF), a novel immune evasion factor of Streptococcus pyogenes. | Virulence | 2022 | 35094646 | PubTator, text mining | PubMed |
| Compstatins: the dawn of clinical C3-targeted complement inhibition. | Trends Pharmacol Sci | 2022 | 35090732 | PubTator, text mining | PubMed |
| Genetic screening of early-onset patients with systemic lupus erythematosus by a targeted next-generation sequencing gene panel. | Lupus | 2022 | 35086391 | PubTator, text mining | PubMed |
| Inherited defects in the complement system. | Pediatr Allergy Immunol | 2022 | 35080299 | PubTator, text mining | PubMed |
| Proteomics Profiling of Human Synovial Fluid Suggests Increased Protein Interplay in Early-Osteoarthritis (OA) That Is Lost in Late-Stage OA. | Mol Cell Proteomics | 2022 | 35074580 | PubTator, text mining | PubMed |
| Urine Proteomics for Noninvasive Monitoring of Biomarkers in Bronchopulmonary Dysplasia. | Neonatology | 2022 | 35073553 | PubTator, text mining | PubMed |
| Complement regulation in ovine lymph nodes during early pregnancy. | Exp Ther Med | 2022 | 35069847 | PubTator, text mining | PubMed |
| Engineered human antibodies for the opsonization and killing of Staphylococcus aureus. | Proc Natl Acad Sci U S A | 2022 | 35058363 | PubTator, text mining | PubMed |
| Complement Factor D Is a Novel Biomarker and Putative Therapeutic Target in Cutaneous Squamous Cell Carcinoma. | Cancers (Basel) | 2022 | 35053469 | PubTator, text mining | PubMed |
| Afatinib and Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (ALPHA Study): A Phase II Study with Biomarker Analysis. | Clin Cancer Res | 2022 | 35046059 | PubTator, text mining | PubMed |
| Cryptochrome proteins regulate the circadian intracellular behavior and localization of PER2 in mouse suprachiasmatic nucleus neurons. | Proc Natl Acad Sci U S A | 2022 | 35046033 | PubTator, text mining | PubMed |
| Proteomic profiling identifies novel diagnostic biomarkers and molecular subtypes for mucinous tubular and spindle cell carcinoma of the kidney. | J Pathol | 2022 | 35043389 | PubTator, text mining | PubMed |
| Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality. | Med Microbiol Immunol | 2022 | 35034207 | PubTator, text mining | PubMed |
| Complement activation induces excessive T cell cytotoxicity in severe COVID-19. | Cell | 2022 | 35032429 | PubTator, text mining | PubMed |
| Persistent coxsackievirus B1 infection triggers extensive changes in the transcriptome of human pancreatic ductal cells. | iScience | 2022 | 35024587 | PubTator, text mining | PubMed |
| The Different Immune Responses by Age Are due to the Ability of the Fetal Immune System to Secrete Primal Immunoglobulins Responding to Unexperienced Antigens. | Int J Biol Sci | 2022 | 35002513 | PubTator, text mining | PubMed |
| Complement cascade inhibition in geographic atrophy: a review. | Eye (Lond) | 2022 | 34999723 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/715/papers?page=35